UPDATE 1-Cancer patient dies after Ziopharm experimental drug therapy

July 15 (Reuters) - Ziopharm Oncology Inc said a

brain cancer patient died of cranial bleeding about two weeks

after starting treatment with the gene therapy developer's lead

experimental drug,...

Read more